Glenn Pierce serves as Executive at Voyager Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Glenn Pierce has executed 8 insider transactions totaling $155.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 5, 2022 involved selling 26,437 shares valued at $0.
Glenn Pierce currently holds 16,788 shares of Voyager Therapeutics, Inc. (VYGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glenn Pierce has been a net buyer of VYGR stock. They have purchased $92.2K and sold $63.7K worth of shares.
Glenn Pierce's most recent insider trade was on Oct 5, 2022, when they sold 26,437 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.70 |
| Discretionary |
| Jun 14, 2022 | GBT | $0 | Option Exercise | 3,600 | $N/A | Discretionary |
| Jan 13, 2022 | VYGR | $0 | Award | 26,300 | $N/A | Discretionary |
| Jun 17, 2021 | GBT | $0 | Option Exercise | 3,037 | $N/A | Discretionary |
| Sep 10, 2020 | GBT | $225.4K | Option Exercise | 15,000 | $15.03 | Discretionary |
| Jun 17, 2020 | GBT | $0 | Option Exercise | 4,800 | $N/A | Discretionary |
| Sep 12, 2018 | VYGR | $92.2K | Purchase | 5,000 | $18.44 | Discretionary |